Skye Bioscience
SKYE
39 hedge funds and large institutions have $9.91M invested in Skye Bioscience in 2026 Q1 according to their latest regulatory filings, with 5 funds opening new positions, 9 increasing their positions, 8 reducing their positions, and 14 closing their positions.
13% more repeat investments, than reductions
Existing positions increased: 9 | Existing positions reduced: 8
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
2% less ownership
Funds ownership: 50.32% → 48.32% (-2%)
18% less capital invested
Capital invested by funds: $12.1M → $9.91M (-$2.18M)
22% less funds holding
Funds holding: 50 → 39 (-11)
36% less call options, than puts
Call options by funds: $25K | Put options by funds: $39K
64% less first-time investments, than exits
New positions opened: 5 | Existing positions closed: 14
Top Buyers
| 1 |
SFM
Sphera Funds Management
Tel Aviv,
Israel
|
+$163K |
| 2 |
BBA
Baker Bros. Advisors
New York
|
+$102K |
| 3 |
Geode Capital Management
Boston,
Massachusetts
|
+$54.7K |
| 4 |
UBS Group
Zurich,
Switzerland
|
+$26.5K |
| 5 |
BlackRock
New York
|
+$3.5K |
Top Sellers
| 1 |
Millennium Management
New York
|
-$99.6K |
| 2 |
SSA
Schonfeld Strategic Advisors
New York
|
-$70K |
| 3 |
Two Sigma Investments
New York
|
-$21.2K |
| 4 |
HF
HRT Financial
New York
|
-$20K |
| 5 |
Jane Street
New York
|
-$18.5K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
DWS
51
Dynamic Wealth Strategies
Granite Bay,
California
| – | -$6 | -8 | Closed |
|
52
Wells Fargo
San Francisco,
California
| – | -$1 | -1 | Closed |
|
53
Royal Bank of Canada
Toronto,
Ontario, Canada
| – | +$2 | +3 | +2% |
|
SKYE Hedge Fund Activity: Q1 2026 in Review
39 of the 8,126 institutional investors tracked by Wall St. Rank reported a position in Skye Bioscience (SKYE) for Q1 2026, worth a combined $9.91M — down 18% from $12.1M a quarter earlier.
Sellers outnumbered buyers: 14 funds closed out of SKYE and 5 opened new positions — a net loss of 9 holders — while 8 trimmed existing stakes and 9 added.
The largest buyer was Sphera Funds Management, adding an estimated $163K. The largest seller was Millennium Management, cutting an estimated $99.6K.
- 39 institutional investors held Skye Bioscience (SKYE) as of Q1 2026, down from 50 in Q4 2025.
- Funds reported $9.91M of Skye Bioscience stock for Q1 2026, down 18% quarter-over-quarter.
- 5 funds opened new Skye Bioscience positions in Q1 2026 and 14 closed out, a net change of -9 holders.
- The largest Skye Bioscience buyer in Q1 2026 was Sphera Funds Management, an estimated $163K added.
- The largest Skye Bioscience seller in Q1 2026 was Millennium Management, an estimated $99.6K sold.
Based on aggregated 13F filings for Q1 2026.